SripalBangaloreMDMHA, FACC, FAHA, FSCAI
Cardiology • New York, NYInterventional Cardiology
Professor of Medicine, Director of Invasive and Interventional Cardiology, Director of Complex Coronary Intervention, Interventional Director, Adult ECMO, PERT and MCS Program, Bellevue Hospital Center, Director of Research for the Cardiac Catheterization Laboratory
Dr. Bangalore is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
NYU Langone Health 530 First Avenue
SKI 9R109
New York, NY 10016Phone+1 212-263-3540Fax+1 212-263-3988
Summary
- Dr. Sripal Bangalore is a cardiologist in New York, NY. He specializes in interventional cardiology and preventive cardiology and is experienced in hypertension, coronary artery disease, preventive cardiology, cardiac critical care, and coronary restenosis. Dr. Bangalore's expertise is in complex coronary intervention including chronic total occlusion, zero contrast PCI for those with advanced CKD, advanced mechanical circulatory support device including ECMO and in percutaneous extraction of right sided masses/thrombus and pulmonary emboli.
Education & Training
Brigham and Women's HospitalPost-Doctoral Fellowship, 2009 - 2010- Brigham and Women's HospitalFellowship, Interventional Cardiology, 2008 - 2010
Icahn School of Medicine at Mount Sinai/Morningside/BronxCareFellowship, Cardiovascular Disease, 2005 - 2008- Icahn School of Medicine at Mount Sinai/Morningside/WestResidency, Internal Medicine, 2003 - 2005
- Icahn School of Medicine at Mount Sinai/Morningside/WestInternship, Internal Medicine, 2002 - 2003
Bangalore Medical CollegeClass of 2000
Certifications & Licensure
NY State Medical License 2010 - 2025
MA State Medical License 2008 - 2010
OH State Medical License 2008 - 2009- American Board of Internal Medicine Cardiovascular Disease
- American Board of Internal Medicine Interventional Cardiology
- CBNCNuclear Cardiology
Clinical Trials
- BARCONA: A Study of Effects of Bardoxolone Methyl in Participants With SARS-Corona Virus-2 (COVID-19) Start of enrollment: 2020 Sep 08
Publications & Presentations
PubMed
- 141 citationsRationale and design of the dual antiplatelet therapy study, a prospective, multicenter, randomized, double-blind trial to assess the effectiveness and safety of 12 ve...Laura Mauri, Dean J. Kereiakes, Sharon-Lise T. Normand, Stephen D. Wiviott, David Cohen
American Heart Journal. 2010-12-01 - 55 citationsOutcomes with coronary artery bypass graft surgery versus percutaneous coronary intervention for patients with diabetes mellitus: can newer generation drug-eluting ste...Sripal Bangalore, Bora Toklu, Frederick Feit
Circulation. Cardiovascular Interventions. 2014-08-01 - 199 citationsClinical outcomes with β-blockers for myocardial infarction: a meta-analysis of randomized trials.Sripal Bangalore, Harikrishna Makani, Martha J. Radford, Kamia Thakur, Bora Toklu
The American Journal of Medicine. 2014-10-01
Press Mentions
90% of Adults in the U.S. At Risk of Heart Disease. What to Know About Metabolic SyndromeMay 8th, 2024- Weight Fluctuation a Normal Daily Occurrence, but Long-Term Ups and Downs Can Be HarmfulDecember 3rd, 2020
- 'Surprisingly' High Number of Adults in the U.S. At Risk of Heart SyndromeMay 9th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
